- Stock: In Stock
- Brand: Square Pharmaceuticals
- Product ID: Levosalbutamol
100% Secure Payment
bKash | Nagad | Cards via SSLCommerz | COD
Monthly Medicines Available | Free Delivery on Eligible Orders
| Generic Name | Levosalbutamol |
|---|---|
| Strength | 2 mg |
| Dosage Form | Tablet |
| Manufacturer | Square Pharmaceuticals PLC |
| Therapeutic Class | Short-acting selective β2-adrenoceptor stimulants |
| Pack Size | 5×10 (50 tablets) |
Overview
Levostar 2 mg Tablet contains Levosalbutamol, a selective beta-2 adrenoceptor agonist bronchodilator manufactured by Square Pharmaceuticals PLC. The 2 mg formulation provides a higher dose for patients requiring greater bronchodilatory effect. Levosalbutamol is the pharmacologically active (R)-enantiomer of salbutamol and acts by stimulating beta-2 receptors in airway smooth muscle, causing bronchodilation and relief from bronchospasm without the adverse effects associated with the (S)-enantiomer.
Levostar 2 mg is indicated for the treatment and prevention of bronchospasm in adults and adolescents (12 years and older) with reversible obstructive airway disease, including bronchial asthma and COPD.
Dosage and Administration
Adults and adolescents (above 12 years): 1–2 mg (one Levostar 1 mg tablet or one Levostar 2 mg tablet) three times daily, based on clinical response and tolerability.
Tablets are for oral administration. The lowest effective dose should be used. If symptoms worsen or additional doses are required more frequently than usual, medical reassessment is required.
Interaction
Concurrent use of other sympathomimetic bronchodilators or epinephrine requires caution due to potential additive cardiovascular effects. Beta-blockers may antagonise the bronchodilatory effect. Xanthine derivatives, corticosteroids, and diuretics used concomitantly may increase the risk of hypokalaemia, especially in acute severe asthma.
Contraindications
Levostar is contraindicated in patients with known hypersensitivity to Levosalbutamol or any component of the formulation.
Side Effects
Palpitations, fine skeletal muscle tremors, muscle cramps, and hypokalaemia may occur. Other effects include nausea, vomiting, substernal or epigastric discomfort, and diarrhoea. These are generally dose-dependent and tend to diminish with continued use.
Pregnancy and Lactation
Use during pregnancy only if the benefit justifies the potential risk to the fetus. It is not established whether Levosalbutamol is excreted in breast milk; caution is advised during lactation.
Precautions and Warnings
In acute severe asthma, caution is required as hypokalaemia risk may be potentiated by hypoxia and by concurrent use of xanthine derivatives, steroids, and diuretics. Monitor serum potassium in high-risk situations. Overuse suggests inadequate asthma control and warrants medical review. In overdose, symptomatic care is appropriate; a cardioselective beta-blocker may be considered with caution if bronchospasm is not a concern.
Storage Conditions
Store in a cool, dry place, protected from light. Keep out of reach of children.
Frequently Asked Questions
Q: How does Levostar 2 mg differ from Levostar 1 mg?
A: Levostar 2 mg provides twice the dose of Levosalbutamol per tablet. It is used for adults and adolescents who require a higher bronchodilatory dose. Levostar 1 mg is used for both children (6–11 years) at the lower dose and adults who need less potent initial therapy.
Q: How often should Levostar 2 mg be taken?
A: The standard adult dose is 1–2 mg three times daily. The physician may adjust based on the patient's response and tolerability. Do not exceed the recommended dose without medical guidance.
